• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by SNDL Inc.

    4/17/25 8:45:02 AM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $SNDL alert in real time by email
    6-K 1 ss4719516_6k.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

    Form 6-K

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16 OF THE

    SECURITIES EXCHANGE ACT OF 1934

    For the month of April 2025

    Commission File Number 001-39005

    SNDL INC.

    (Registrant’s name)

    #101, 17220 Stony Plain Road NW

    Edmonton, AB T5S 1K6

    Tel.: (780) 944-9994

    (Address of principal executive offices)

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

    Form 20-F ☐ Form 40-F ☒

     

     

     

     

     

     

     

     

     

     

     
     

     

    INCORPORATION BY REFERENCE

     

    This report on Form 6-K shall be deemed to be incorporated by reference in SNDL Inc.’s registration statements on Form S-8 (File No. 333-286169, File No. 333-278683, File No. 333-269242, File No. 333-267510, File No. 333-262233 and File No. 333-233156) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     
     

     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      SNDL INC.
    Date:  April 17, 2025 By: /s/ Matthew Husson
      Name: Matthew Husson
      Title: General Counsel & Corporate Secretary

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     
     

     

    EXHIBITS

    Exhibit   Description of Exhibit
    99.1   Material Change Report, dated April 17, 2025
    99.2   Arrangement Agreement, dated April 9, 2025, by and between SNDL Inc. and 1CM Inc.
    99.3   Voting Support Agreement, dated April 9, 2025, by and between SNDL Inc. and Harshil Jayantibhai Chovatiya
    99.4   Voting Support Agreement, dated April 9, 2025, by and between SNDL Inc. and Tanvi Rajnish Bhandari
    99.5   Voting Support Agreement, dated April 9, 2025, by and between SNDL Inc. and Lucas Anthony Leone

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Get the next $SNDL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SNDL

    DatePrice TargetRatingAnalyst
    7/17/2024Speculative Buy
    Canaccord Genuity
    8/16/2022$5.00Hold → Speculative Buy
    Canaccord Genuity
    5/3/2022$0.60 → $0.70Underperform → Market Perform
    BMO Capital Markets
    More analyst ratings